table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biosimilars of Monoclonal Antibody Market Size Analysis from 2022 to 2027
1.5.1 Global Biosimilars of Monoclonal Antibody Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biosimilars of Monoclonal Antibody Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biosimilars of Monoclonal Antibody Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biosimilars of Monoclonal Antibody Industry Impact
Chapter 2 Global Biosimilars of Monoclonal Antibody Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimilars of Monoclonal Antibody (Volume and Value) by Type
2.1.1 Global Biosimilars of Monoclonal Antibody Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Type (2016-2021)
2.2 Global Biosimilars of Monoclonal Antibody (Volume and Value) by Application
2.2.1 Global Biosimilars of Monoclonal Antibody Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Application (2016-2021)
2.3 Global Biosimilars of Monoclonal Antibody (Volume and Value) by Regions
2.3.1 Global Biosimilars of Monoclonal Antibody Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biosimilars of Monoclonal Antibody Consumption by Regions (2016-2021)
4.2 North America Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biosimilars of Monoclonal Antibody Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biosimilars of Monoclonal Antibody Market Analysis
5.1 North America Biosimilars of Monoclonal Antibody Consumption and Value Analysis
5.1.1 North America Biosimilars of Monoclonal Antibody Market Under COVID-19
5.2 North America Biosimilars of Monoclonal Antibody Consumption Volume by Types
5.3 North America Biosimilars of Monoclonal Antibody Consumption Structure by Application
5.4 North America Biosimilars of Monoclonal Antibody Consumption by Top Countries
5.4.1 United States Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
5.4.2 Canada Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
5.4.3 Mexico Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biosimilars of Monoclonal Antibody Market Analysis
6.1 East Asia Biosimilars of Monoclonal Antibody Consumption and Value Analysis
6.1.1 East Asia Biosimilars of Monoclonal Antibody Market Under COVID-19
6.2 East Asia Biosimilars of Monoclonal Antibody Consumption Volume by Types
6.3 East Asia Biosimilars of Monoclonal Antibody Consumption Structure by Application
6.4 East Asia Biosimilars of Monoclonal Antibody Consumption by Top Countries
6.4.1 China Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
6.4.2 Japan Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
6.4.3 South Korea Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 7 Europe Biosimilars of Monoclonal Antibody Market Analysis
7.1 Europe Biosimilars of Monoclonal Antibody Consumption and Value Analysis
7.1.1 Europe Biosimilars of Monoclonal Antibody Market Under COVID-19
7.2 Europe Biosimilars of Monoclonal Antibody Consumption Volume by Types
7.3 Europe Biosimilars of Monoclonal Antibody Consumption Structure by Application
7.4 Europe Biosimilars of Monoclonal Antibody Consumption by Top Countries
7.4.1 Germany Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.2 UK Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.3 France Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.4 Italy Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.5 Russia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.6 Spain Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
7.4.9 Poland Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biosimilars of Monoclonal Antibody Market Analysis
8.1 South Asia Biosimilars of Monoclonal Antibody Consumption and Value Analysis
8.1.1 South Asia Biosimilars of Monoclonal Antibody Market Under COVID-19
8.2 South Asia Biosimilars of Monoclonal Antibody Consumption Volume by Types
8.3 South Asia Biosimilars of Monoclonal Antibody Consumption Structure by Application
8.4 South Asia Biosimilars of Monoclonal Antibody Consumption by Top Countries
8.4.1 India Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biosimilars of Monoclonal Antibody Market Analysis
9.1 Southeast Asia Biosimilars of Monoclonal Antibody Consumption and Value Analysis
9.1.1 Southeast Asia Biosimilars of Monoclonal Antibody Market Under COVID-19
9.2 Southeast Asia Biosimilars of Monoclonal Antibody Consumption Volume by Types
9.3 Southeast Asia Biosimilars of Monoclonal Antibody Consumption Structure by Application
9.4 Southeast Asia Biosimilars of Monoclonal Antibody Consumption by Top Countries
9.4.1 Indonesia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.2 Thailand Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.3 Singapore Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.5 Philippines Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biosimilars of Monoclonal Antibody Market Analysis
10.1 Middle East Biosimilars of Monoclonal Antibody Consumption and Value Analysis
10.1.1 Middle East Biosimilars of Monoclonal Antibody Market Under COVID-19
10.2 Middle East Biosimilars of Monoclonal Antibody Consumption Volume by Types
10.3 Middle East Biosimilars of Monoclonal Antibody Consumption Structure by Application
10.4 Middle East Biosimilars of Monoclonal Antibody Consumption by Top Countries
10.4.1 Turkey Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.3 Iran Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.5 Israel Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.6 Iraq Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.7 Qatar Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
10.4.9 Oman Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 11 Africa Biosimilars of Monoclonal Antibody Market Analysis
11.1 Africa Biosimilars of Monoclonal Antibody Consumption and Value Analysis
11.1.1 Africa Biosimilars of Monoclonal Antibody Market Under COVID-19
11.2 Africa Biosimilars of Monoclonal Antibody Consumption Volume by Types
11.3 Africa Biosimilars of Monoclonal Antibody Consumption Structure by Application
11.4 Africa Biosimilars of Monoclonal Antibody Consumption by Top Countries
11.4.1 Nigeria Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
11.4.2 South Africa Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
11.4.3 Egypt Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
11.4.4 Algeria Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
11.4.5 Morocco Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biosimilars of Monoclonal Antibody Market Analysis
12.1 Oceania Biosimilars of Monoclonal Antibody Consumption and Value Analysis
12.2 Oceania Biosimilars of Monoclonal Antibody Consumption Volume by Types
12.3 Oceania Biosimilars of Monoclonal Antibody Consumption Structure by Application
12.4 Oceania Biosimilars of Monoclonal Antibody Consumption by Top Countries
12.4.1 Australia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 13 South America Biosimilars of Monoclonal Antibody Market Analysis
13.1 South America Biosimilars of Monoclonal Antibody Consumption and Value Analysis
13.1.1 South America Biosimilars of Monoclonal Antibody Market Under COVID-19
13.2 South America Biosimilars of Monoclonal Antibody Consumption Volume by Types
13.3 South America Biosimilars of Monoclonal Antibody Consumption Structure by Application
13.4 South America Biosimilars of Monoclonal Antibody Consumption Volume by Major Countries
13.4.1 Brazil Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.2 Argentina Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.3 Columbia Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.4 Chile Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.6 Peru Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biosimilars of Monoclonal Antibody Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biosimilars of Monoclonal Antibody Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer Biosimilars of Monoclonal Antibody Product Specification
14.1.3 Pfizer Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Roche
14.2.1 Roche Company Profile
14.2.2 Roche Biosimilars of Monoclonal Antibody Product Specification
14.2.3 Roche Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Eli Lilly
14.3.1 Eli Lilly Company Profile
14.3.2 Eli Lilly Biosimilars of Monoclonal Antibody Product Specification
14.3.3 Eli Lilly Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Bayer
14.4.1 Bayer Company Profile
14.4.2 Bayer Biosimilars of Monoclonal Antibody Product Specification
14.4.3 Bayer Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Amgen
14.5.1 Amgen Company Profile
14.5.2 Amgen Biosimilars of Monoclonal Antibody Product Specification
14.5.3 Amgen Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Sanofi-Aventis
14.6.1 Sanofi-Aventis Company Profile
14.6.2 Sanofi-Aventis Biosimilars of Monoclonal Antibody Product Specification
14.6.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Johnson & Johnson
14.7.1 Johnson & Johnson Company Profile
14.7.2 Johnson & Johnson Biosimilars of Monoclonal Antibody Product Specification
14.7.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Novo Nordisk
14.8.1 Novo Nordisk Company Profile
14.8.2 Novo Nordisk Biosimilars of Monoclonal Antibody Product Specification
14.8.3 Novo Nordisk Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Merck
14.9.1 Merck Company Profile
14.9.2 Merck Biosimilars of Monoclonal Antibody Product Specification
14.9.3 Merck Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 GSK
14.10.1 GSK Company Profile
14.10.2 GSK Biosimilars of Monoclonal Antibody Product Specification
14.10.3 GSK Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 BMS
14.11.1 BMS Company Profile
14.11.2 BMS Biosimilars of Monoclonal Antibody Product Specification
14.11.3 BMS Biosimilars of Monoclonal Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biosimilars of Monoclonal Antibody Market Forecast (2022-2027)
15.1 Global Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biosimilars of Monoclonal Antibody Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biosimilars of Monoclonal Antibody Value and Growth Rate Forecast (2022-2027)
15.2 Global Biosimilars of Monoclonal Antibody Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biosimilars of Monoclonal Antibody Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biosimilars of Monoclonal Antibody Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biosimilars of Monoclonal Antibody Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biosimilars of Monoclonal Antibody Consumption Forecast by Type (2022-2027)
15.3.2 Global Biosimilars of Monoclonal Antibody Revenue Forecast by Type (2022-2027)
15.3.3 Global Biosimilars of Monoclonal Antibody Price Forecast by Type (2022-2027)
15.4 Global Biosimilars of Monoclonal Antibody Consumption Volume Forecast by Application (2022-2027)
15.5 Biosimilars of Monoclonal Antibody Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
